Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lixian Yang

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Endocrinology|January 24, 2024
Obesity and its impact on female reproductive health: unraveling the connectionsLei Zheng, Lixian Yang, Ziru Guo, et al.
Oncology Letters|June 19, 2023
​Efficacy and safety of pyrotinib in combination with albumin‑bound paclitaxel for the treatment of HER2‑positive advanced breast cancer: A real‑world studyLixian Yang, Lei Zheng, Fanting Kong, et al.
Scientific Reports|January 22, 2024
Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltrationLixian Yang, Liu Yang, Fanting Kong, et al.
Journal of Cancer|April 27, 2026
Myeloid-Derived Suppressor Cells and Radiotherapy: Regulation and Clinical ImplicationsLixian Yang, Ke Wang, Wenjie Zeng, et al.
Oncology Letters|April 11, 2022
miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherinLixian Yang, Shuo Liu, Liu Yang, et al.
Oncology Letters|May 3, 2024
Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancerLixian Yang, Shiyu Zhang, Lei Zheng, et al.
Scientific Reports|April 26, 2024
A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodesLiu Yang, Xueyi Zhao, Lixian Yang, et al.
International Journal of General Medicine|March 6, 2025
miR-145-5p Inhibits HER2-Positive Breast Cancer Cells via Targeting ARF6Lixian Yang, Wei Dang, Fanting Kong, et al.
Oncology Letters|June 14, 2024
Comprehensive pan‑cancer analysis of MTDH for human tumor prognosis and as an immunological biomarker including breast and kidney cancerLixian Yang, Mingqiang Han, Xiaoling Zhao, et al.
Journal of Animal Science and Biotechnology|April 14, 2026
RFLNA mitigates heat stress-impaired chondrocyte proliferation and vertebral development through cytoskeletal regulation in pigsXiaoyang Yang, Yuxuan Xie, Yabiao Luo, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|January 24, 2024
Obesity and its impact on female reproductive health: unraveling the connectionsLei Zheng, Lixian Yang, Ziru Guo, et al.
Oncology Letters|June 19, 2023
​Efficacy and safety of pyrotinib in combination with albumin‑bound paclitaxel for the treatment of HER2‑positive advanced breast cancer: A real‑world studyLixian Yang, Lei Zheng, Fanting Kong, et al.
Scientific Reports|January 22, 2024
Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltrationLixian Yang, Liu Yang, Fanting Kong, et al.
Journal of Cancer|April 27, 2026
Myeloid-Derived Suppressor Cells and Radiotherapy: Regulation and Clinical ImplicationsLixian Yang, Ke Wang, Wenjie Zeng, et al.
Oncology Letters|April 11, 2022
miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherinLixian Yang, Shuo Liu, Liu Yang, et al.
Oncology Letters|May 3, 2024
Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancerLixian Yang, Shiyu Zhang, Lei Zheng, et al.
Scientific Reports|April 26, 2024
A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodesLiu Yang, Xueyi Zhao, Lixian Yang, et al.
International Journal of General Medicine|March 6, 2025
miR-145-5p Inhibits HER2-Positive Breast Cancer Cells via Targeting ARF6Lixian Yang, Wei Dang, Fanting Kong, et al.
Oncology Letters|June 14, 2024
Comprehensive pan‑cancer analysis of MTDH for human tumor prognosis and as an immunological biomarker including breast and kidney cancerLixian Yang, Mingqiang Han, Xiaoling Zhao, et al.
Journal of Animal Science and Biotechnology|April 14, 2026
RFLNA mitigates heat stress-impaired chondrocyte proliferation and vertebral development through cytoskeletal regulation in pigsXiaoyang Yang, Yuxuan Xie, Yabiao Luo, et al.
Pageof 5